114 related articles for article (PubMed ID: 29377518)
21. Flagellin as carrier and adjuvant in cocaine vaccine development.
Lockner JW; Eubanks LM; Choi JL; Lively JM; Schlosburg JE; Collins KC; Globisch D; Rosenfeld-Gunn RJ; Wilson IA; Janda KD
Mol Pharm; 2015 Feb; 12(2):653-62. PubMed ID: 25531528
[TBL] [Abstract][Full Text] [Related]
22. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility.
Smith KD; Andersen-Nissen E; Hayashi F; Strobe K; Bergman MA; Barrett SL; Cookson BT; Aderem A
Nat Immunol; 2003 Dec; 4(12):1247-53. PubMed ID: 14625549
[TBL] [Abstract][Full Text] [Related]
23. Dissection and localization of the immunostimulating domain of Edwardsiella tarda FliC.
Jiao XD; Hu YH; Sun L
Vaccine; 2010 Aug; 28(34):5635-40. PubMed ID: 20580470
[TBL] [Abstract][Full Text] [Related]
24. Enhanced humoural and cellular immune responses to influenza H7N9 antigen HA1-2 fused with flagellin in chickens.
Song L; Xiong D; Hu M; Kang X; Pan Z; Jiao X
BMC Vet Res; 2017 Jun; 13(1):190. PubMed ID: 28637471
[TBL] [Abstract][Full Text] [Related]
25. Crystal structure of Bacillus cereus flagellin and structure-guided fusion-protein designs.
Il Kim M; Lee C; Park J; Jeon BY; Hong M
Sci Rep; 2018 Apr; 8(1):5814. PubMed ID: 29643437
[TBL] [Abstract][Full Text] [Related]
26. Protein nanoparticle vaccine based on flagellin carrier fused to influenza conserved epitopes confers full protection against influenza A virus challenge.
Deng L; Kim JR; Chang TZ; Zhang H; Mohan T; Champion JA; Wang BZ
Virology; 2017 Sep; 509():82-89. PubMed ID: 28622575
[TBL] [Abstract][Full Text] [Related]
27. Clostridium difficile flagellin FliC: Evaluation as adjuvant and use in a mucosal vaccine against Clostridium difficile.
Bruxelle JF; Mizrahi A; Hoÿs S; Collignon A; Janoir C; Péchiné S
PLoS One; 2017; 12(11):e0187212. PubMed ID: 29176760
[TBL] [Abstract][Full Text] [Related]
28. The N-terminal D1 domain of Treponema pallidum flagellin binding to TLR5 is required but not sufficient in activation of TLR5.
Xu M; Xie Y; Tan M; Zheng K; Xiao Y; Jiang C; Zhao F; Zeng T; Wu Y
J Cell Mol Med; 2019 Nov; 23(11):7490-7504. PubMed ID: 31493340
[TBL] [Abstract][Full Text] [Related]
29. Duplicated Flagellins in Pseudomonas Divergently Contribute to Motility and Plant Immune Elicitation.
Luo Y; Wang J; Gu YL; Zhang LQ; Wei HL
Microbiol Spectr; 2023 Feb; 11(1):e0362122. PubMed ID: 36629446
[TBL] [Abstract][Full Text] [Related]
30. Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice.
Asadi Karam MR; Oloomi M; Mahdavi M; Habibi M; Bouzari S
Vaccine; 2013 Feb; 31(8):1210-6. PubMed ID: 23306365
[TBL] [Abstract][Full Text] [Related]
31. Co-utilization of a TLR5 agonist and nano-formulation of HIV-1 vaccine candidate leads to increased vaccine immunogenicity and decreased immunogenic dose: A preliminary study.
Rostami H; Ebtekar M; Ardestani MS; Yazdi MH; Mahdavi M
Immunol Lett; 2017 Jul; 187():19-26. PubMed ID: 28479111
[TBL] [Abstract][Full Text] [Related]
32. Deimmunization of flagellin adjuvant for clinical application.
Rhee JH; Khim K; Puth S; Choi Y; Lee SE
Curr Opin Virol; 2023 Jun; 60():101330. PubMed ID: 37084463
[TBL] [Abstract][Full Text] [Related]
33. Structural basis for stabilization of the hypervariable D3 domain of Salmonella flagellin upon filament formation.
Muskotál A; Seregélyes C; Sebestyén A; Vonderviszt F
J Mol Biol; 2010 Nov; 403(4):607-15. PubMed ID: 20868693
[TBL] [Abstract][Full Text] [Related]
34. Evasion of Toll-like receptor 5 by flagellated bacteria.
Andersen-Nissen E; Smith KD; Strobe KL; Barrett SL; Cookson BT; Logan SM; Aderem A
Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9247-52. PubMed ID: 15956202
[TBL] [Abstract][Full Text] [Related]
35. Incorporation of RG1 epitope concatemers into a self-adjuvanting Flagellin-L2 vaccine broaden durable protection against cutaneous challenge with diverse human papillomavirus genotypes.
Kalnin K; Chivukula S; Tibbitts T; Yan Y; Stegalkina S; Shen L; Cieszynski J; Costa V; Sabharwal R; Anderson SF; Christensen N; Jagu S; Roden RBS; Kleanthous H
Vaccine; 2017 Sep; 35(37):4942-4951. PubMed ID: 28778613
[TBL] [Abstract][Full Text] [Related]
36. Activation of NF-kappaB-dependent gene expression by Salmonella flagellins FliC and FljB.
Simon R; Samuel CE
Biochem Biophys Res Commun; 2007 Mar; 355(1):280-5. PubMed ID: 17292856
[TBL] [Abstract][Full Text] [Related]
37. Helicobacter pylori flagellin: TLR5 evasion and fusion-based conversion into a TLR5 agonist.
Kim JH; Namgung B; Jeon YJ; Song WS; Lee J; Kang SG; Yoon SI
Biochem Biophys Res Commun; 2018 Nov; 505(3):872-878. PubMed ID: 30301528
[TBL] [Abstract][Full Text] [Related]
38. Recombinant Bacillus subtilis flagellin Hag is a potent immunostimulant with reduced proinflammatory properties compared to Salmonella enterica serovar Typhimurium FljB.
Côté-Cyr M; Gauthier L; Zottig X; Bourgault S; Archambault D
Vaccine; 2022 Jan; 40(1):11-17. PubMed ID: 34844822
[TBL] [Abstract][Full Text] [Related]
39. In silico and in vivo studies of truncated forms of flagellin (FliC) of enteroaggregative Escherichia coli fused to FimH from uropathogenic Escherichia coli as a vaccine candidate against urinary tract infections.
Savar NS; Jahanian-Najafabadi A; Mahdavi M; Shokrgozar MA; Jafari A; Bouzari S
J Biotechnol; 2014 Apr; 175():31-7. PubMed ID: 24530504
[TBL] [Abstract][Full Text] [Related]
40. DNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-Adjuvant.
Nyström S; Bråve A; Falkeborn T; Devito C; Rissiek B; Johansson DX; Schröder U; Uematsu S; Akira S; Hinkula J; Applequist SE
Vaccines (Basel); 2013 Sep; 1(4):415-43. PubMed ID: 26344341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
